Statistics

Total Visits

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study22

Select a period of time:

Number of views in the range

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study11

Views

Views
May 20242
June 20243
July 20241
August 20243
September 20241
October 20240
November 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
United Kingdom2
 

Top cities views

Views
Chicago2
DeKalb1
Fort Worth1
Prineville1